CORE
🇺🇦Â
 make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
Phase II trial of combined modality therapy (cmt) with myeloid growth factors in patients with locally advanced non-small cell lung cancer (NSCLC)
Author
Blaustein  A.
Cusnir  M.
+4Â more
Lilenbaum  R.
Pizzolato  J.
Samuels  M.
Taffaro-Neskey  M.
Publication venue
Publication date
20/05/2008
Field of study
No full text
Crossref
University of Miami: Scholarship Miami
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
Author
Amy D Rock
Amy Sion
+57Â more
Andie R Edwards
Bergamaschi
Borghaei
Carol Sherman
Carsten Krieg
Catherine M Sanders
Cheung
Chiou
Conlon
Desbois
Dubois
Elizabeth G Hill
Elizabeth Garrett-Mayer
Elpek
Emily K Jeng
Erik C Yusko
Garrido
Harris
Hellmann
Hing C Wong
Hirakawa
Horn
Jack O Egan
James G Ravenel
Jeffrey S Miller
John M Wrangle
Joni Harris
Julie A Rytlewski
Kate Anderton
Kathryn Lindsey
Kazandjian
Kovacs
Langer
Larsen
Manish R Patel
Mark D Robinson
Mark P Rubinstein
Marzena Swiderska-Syn
Michele Taffaro-Neskey
Mohammad Farhad
Naing
Peter R Rhode
Reck
Rhode
Rosenberg
Rosser
Rubinstein
Samantha Suriano
Scharenberg
Snyder
Stoklasek
Tolcher
Tumeh
Vamsidhar Velcheti
van Brummelen
William L Redmond
Wolchok
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
No full text
